Discrepancies in expression and prognostic value of tumor markers in adenocarcinoma and squamous cell carcinoma in cervical cancer

Anticancer Research

Volumn 29, Issue 7, 2009, Pages 2577-2578

  Lindström, Annika K ^a   Tot, Tibor ^b   Stendahl, Ulf ^c   Syrjänen, Stina ^d   Syrjänen, Kari ^e   Hellberg, Dan ^a,f  

^a Center for Clinical Research   (Sweden)

^b FALUN HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF TURKU   (Finland)

^e TURKU UNIVERSITY HOSPITAL   (Finland)

^f UPPSALA UNIVERSITY   (Sweden)

Author keywords

Adenocarcinoma; Cervical cancer; Squamous cell carcinoma; Tumor markers

Indexed keywords

CD4 ANTIGEN; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; HERMES ANTIGEN; KI 67 ANTIGEN; MYC PROTEIN; PROTEIN P27; PROTEIN P53; STRATIFIN; TUMOR MARKER; UVOMORULIN; VASCULOTROPIN;

ADENOCARCINOMA; ARTICLE; CANCER SURVIVAL; CERVICAL ADENOCARCINOMA; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 69249167999     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Liang J, Mittal KR, Wei JJ, Yee H, Chiriboga L and Shukla P: Utility of p16INK4a, CEA, Ki67, p53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions. Int J Gynecol Pathol 26: 71-75, 2007. (Pubitemid 46036962)
2. Nijhuis ER, Nijman HW, Oien KA, Bell A, ten Hoor KA, Reesink-Peters N, Boezen HM, Hollema H and van der Zee AGJ: Loss of MSH2 protein expression is a risk factor in early-stage cervical cancer. J Clin Pathol 60: 824-830, 2007.
3. Gaffney DK, Haslam D, Tsodikov A, Hammond E, Seaman J, Holden J, Lee J, Zempolich K and Dodson M: Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy. Int J Rad Oncol Biol Phys 56: 922-928, 2003. (Pubitemid 36794022)
4. Lindström AK, Stendahl U, Tot T, Lidström BM and Hellberg D: Predicting the outcome of squamous cell carcinoma of the uterine cervix using combinations of individual tumor marker expression. Anticancer Res 27: 1609-1616, 2007.
5. Baltazar F, Filho AL, Pinheiro C, Moreira MAR, Queiroz GS, Oton GJB, Junior AF, Ribeiro LFJ and Schmitt FC: Cyclooxygeanse-2 and epidermal growth factor receptor expressions in different histological subtypes of cervical carcinomas. Int J Gynecol Pathol 26: 235-241, 2007. (Pubitemid 46986055)